Products

With a foundation in materials science and nanotechnology, Nanologica has developed an expertise in chromatography and carries a range of chromatography resins in bulk, as well as prepacked HPLC columns.

NLAB Saga® silica in bulk

A new generation silica for peptide purification by reversed-phase HPLC

NLAB® Idun for IEC

Custom made agarose media for ion exchange chromatography

NLAB® Siv for SEC

Custom made agarose media for size exclusion chromatography

NLAB Saga® HPLC columns

Analytical and semi-prep columns with excellent performance under extreme pH conditions

Chromatography media under development

Nanologica has a development program for non-silica-based purification media for additional applications. Please contact us to learn more.

About us

Nanologica is a Swedish life science group that offers advanced solutions in the development, manufacture and purification of pharmaceutical substances. By combining expertise in materials science, nanotechnology, and chemical process development, with services in contract development and manufacturing, Nanologica provides an integrated platform that supports the entire value chain from early development to commercial production of pharmaceutical substances. Nanologica’s offering enables efficient and scalable production of drug substances, with particular strength within complex molecules and peptide-based drugs, such as treatments for diabetes and obesity. The company positions itself as a long-term partner to the pharmaceutical industry, with the goal of enabling more patients around the world to have access to life-saving treatments and cost-effective medicines. The Group has about 70 employees and is headquartered in Södertälje. Nanologica’s share (ticker NICA) has been listed on Nasdaq Stockholm’s main market since 2022.